Organovo Holdings, Inc. - ONVO Total Company Value

Brandmark of Organovo Corp (ONVO)

Organovo Holdings, Inc. (ONVO) management relies on a powerful scientific foundation, although preclinical research experience has not yet converted into profit. The business generates revenue through the licensing of patents for 3D tissue printing used in pharmaceutical testing. This price chart reflects an Enterprise Value of . The brand maintains its reputation as a recognized pioneer in the bioprinting field, enjoying the trust of the expert community.

organovo.com (ONVO) Total Company Value: for the period 07/04/2022 - 11/01/2026

Organovo Holdings, Inc. (ONVO) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Organovo Holdings|ONVO - Consensus Target
- issuer market value details:
Market Value Organovo|ONVO - Total Company Value
- business book valuation details:
Net Asset Value per Share Organovo|ONVO - Company Book Value|Market Capitalization to Net Assets organovo.com|ONVO - Company Total Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Organovo Holdings, Inc.|ONVO - Long-Term Debt to Capital|Short-Term Debt to Capital organovo.com|ONVO - Company Debts|Debt to Net Assets Ratio Organovo|ONVO - Company Long-Term Debt|Company Current Liabilities Organovo|Quick Ratio organovo.com
- earnings and market multiples details:
ONVO - Net Income
Analysis of all company metrics:Organovo Holdings
Brand item of Organovo Holdings, Inc.

The scale of Organovo Holdings, Inc. (ONVO) as an innovator in 3D bioprinting of tissues for pharmaceutical R&D defines the fundamental basis of the business value. This indicator aggregates market capitalization and net debt to reflect the actual cost of acquiring the company, allowing the total enterprise value to determine a fair premium for the uniqueness of the NovoGen technology.

Competitors of Organovo Holdings, Inc. (ONVO)

ASND: Business Value|MDGL: Real Price to Acquire Entire Company|CORT: Total Company Value|Rhythm Pharmaceuticals (RYTM) - Total Company Value|Total Enterprise Value akerotx.com (AKRO)|Total Company Value Metsera|MoonLake Immunotherapeutics AG - Full Business Value|Enterprise Value CRNX|NAMS (NewAmsterdam Pharma Corp) - Value Adjusted for Debt and Cash|Enterprise Value SLNO (Soleno Therapeutics)|Enterprise Value amicusrx.com FOLD|ETNB - Total Company Value|Value Adjusted for Debt and Cash AGIO (Agios)|Structure Pharma (GPCR) - Total Company Value|Real Price to Acquire Entire Company MiMedx Corp|RZLT (Rezolute, Inc.) - Enterprise Value|Enterprise Value lexpharma.com|Real Price to Acquire Entire Company MBX (MBX Biosciences)|ALT (Altimmune Inc) - Value Adjusted for Debt and Cash|Total Company Value Aardvark Therapeutics Corp AARD|SGMT - Real Price to Acquire Entire Company|BioAge Labs, Inc. - Enterprise Value|Total Enterprise Value biomeafusion.com|QNCX (quincetx.com) - Real Price to Acquire Entire Company|GUTS: Aggregate Business Value|VTVT (vTv Therapeutics, Inc.) - Enterprise Value|Enterprise Value Agape ATP Corp.|Enterprise Value PLUR|Total Company Value SYBX (synlogictx.com)|Total Company Value Lipocine LPCN|Matinas BioPharma Holdings, Inc. (MTNB) - Total Enterprise Value|SPRB - Total Company Value|GLTO: Total Company Value|CTCX: Enterprise Value|LUMO - Company Buyout Price|Total Company Value Radius Recycling